Geron | GERN - Выручка от реализации





Продажи Изменить Дата
Amgen USD 9.9B 340M 2025-12
Bio Techne USD 295.9M 9.34M 2025-12
Cytokinetics USD 17.76M 15.83M 2025-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Exelixis USD 598.66M 860K 2025-12
Genmab DKK 1.06B 36M 2025-12
Geron USD 48.02M 820K 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Incyte USD 1.51B 140M 2025-12
MacroGenics USD 41.23M 31.61M 2025-12
Novartis USD 13.86B 50M 2025-12
Novavax USD 147.14M 76.69M 2025-12